VEGFA and B-cell chronic lymphocytic leukemia: Studies have revealed that exosomes obtained from CLL can modulate the tumour microenvironment by controlling Akt signalling and promoting the lofty expression of CLL promoters, including VEGF (vascular endothelial growth factor).